Westwood Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,900
Closed -$231K 43
2023
Q2
$231K Hold
1,900
0.16% 41
2023
Q1
$292K Hold
1,900
0.26% 40
2022
Q4
$341K Buy
1,900
+150
+9% +$24.5K 0.41% 34
2022
Q3
$207K Sell
1,750
-400
-19% -$60.7K 0.19% 42
2022
Q2
$307K Hold
2,150
0.35% 33
2022
Q1
$370 Sell
2,150
-4,250
-66% -$716K 0.14% 43
2021
Q4
$1.63M Buy
+6,400
New +$1.87M 0.69% 24

Other funds holding MRNA

Westwood Wealth Management's MRNA Position: Q3 2023 in Review

Westwood Wealth Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,900 shares — an estimated $231K sold.

Westwood Wealth Management first reported a position in MRNA in Q4 2021 and held it in 7 quarters. The position peaked at $1.63M in Q4 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Westwood Wealth Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Westwood Wealth Management sold 1,900 Moderna shares in Q3 2023, an estimated $231K.
  • Westwood Wealth Management first reported a position in Moderna in Q4 2021 and held it in 7 quarters.
  • Westwood Wealth Management's Moderna position peaked at $1.63M in Q4 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Westwood Wealth Management's 13F filing for Q3 2023, filed 8 Nov 2023.